Market Overview:

According to a new report by IMIR Market Research on Global the Injectable Drug Delivery (IDD) Market is anticipated to grow at a compound annual growth rate (CAGR) of 9.1% over the forecast period (2024–2031), from its estimated 30.29 billion USD in 2023 to 90.96 billion USD by 2031.

The demand for injectable medicine delivery methods has increased due to the rising incidence of chronic illnesses worldwide. The demand in the industry has increased dramatically due to the growing elderly population worldwide. The market revenue growth of injectable drug delivery is being driven by the growing demand among end users for pre-filled syringes and pen-injectors, along with advancements in medical technologies. Injectable drug delivery devices are widely used because they can deliver drugs both subcutaneously and intravenously. Furthermore, injectable drug delivery works best for treatments that need to be administered directly at the site of action. In addition, a lot of chronic conditions like hemophilia, hepatitis C, cystic fibrosis, and ribose-5-phosphate isomerase deficiency are

A number of the growing use of biologics in the treatment of chronic illnesses, pharmaceutical companies are consequently exploring more advanced drug delivery methodologies and delivery systems. Therefore, a significant increase in injectable drug delivery systems has been observed for the safe delivery of biologics and biosimilars. Additionally, as healthcare costs rise in emerging and developing nations, improved patient numbers and reimbursement practices are achieved, which in turn has increased market demand for injectable medication delivery systems. The main barrier to the market, meanwhile, is the potential for contamination and infections from needle sticks.

The COVID-19 has impacted people all across the world. All industries were negatively impacted, with the pharmaceutical sector being the exception. More diagnostic kits, oxygen cylinders, drugs, vaccines, and ventilators are needed now than there were before the global pandemic. Due to the increased need for injectable devices and other healthcare supplies in recent years, the market for injectable medicine delivery devices has grown. Every country's governments are devoting a significant portion of their financial resources to acquiring and manufacturing more medications and medical supplies. All around the world, immunizations are given to people.

Market Dynamics:

Market Drivers-

Growing Prevalence of Chronic Illnesses 

• The rising incidence of long-term conditions include diabetes, cancer, heart disease, and autoimmune diseases. There are several advantages to using injectable drugs for the treatment of chronic conditions, including precise dosing, controlled release, and improved patient compliance. There is an increasing need for injectable medicines that offer efficient treatment, symptom relief, & disease modification because to the expanding worldwide burden of chronic diseases. The pharmaceutical industry is developing new injectable formulations and delivery methods to close gaps in medicine and improve patient outcomes while treating chronic illnesses. Research, development, & investment in innovative injectable medicines and delivery systems are encouraged by the growing market for injectable medication delivery, that is driven by the increasing number of people with chronic illnesses.

Advances in Biosimilars and Biologics

• The quick development of biologics & biosimilars, which call for specific administration methods and delivery systems. Biologics, such as hormones, cytokines, monoclonal antibodies, and protein therapies, have completely changed the way that many diseases are treated by providing individualized, focused treatments that are very effective and have little adverse effects. In order to ensure accurate dosing and bioavailability, injectable drug delivery systems are essential for enabling the delivery of biologics via under the skin, intramuscular, or intravenous routes. The introduction of biosimilars and the patent expiration for numerous biologic drugs have increased competition in the biologics market, which is driving up demand for patient-friendly & reasonably priced injectable drug delivery solutions. Novel injectable medication delivery technologies, like autoinjectors, pen injectable devices, and needle-free devices, are becoming more and more necessary to improve the comfort of patients, adherence, and treatment outcomes. These technologies are driven by the expanding market for biologics & biosimilars.

Market Trends-

Shift Towards Self-administration and Home Healthcare

• The growing inclination toward at-home medical treatment and self-administration. In order to deliver injectable medications more conveniently at home and cut down on the number of trips to the hospital, patients are looking for choices that are easy to use and convenient. Autoinjectors, pen injectors, & wearable injectors are examples of injectable drug delivery systems that provide patients with greater control and autonomy over their treatment plans while enhancing medication adherence & therapeutic results.  Advanced injectable drug delivery methods that are user-friendly, portable, and work well with a variety of injectable drugs are the focus of pharmaceutical businesses. Moreover, those who take their own injectable drugs can receive remote surveillance and assistance because to advancements related to and digital wellness. This allows for more individualized care and patient involvement in treatment planning. The market expansion for injectable medication delivery systems is anticipated to be driven by the trend toward independence and at-home healthcare.

Emergence of Long-acting Injectable Formulations

• The developing of injection drug formulations with longer half-lives to allow for continuous drug delivery. Long-acting injectables provide several advantages over typical dose forms, including higher adherence among patients, decreased dosing frequency, and improved therapeutic efficacy. Pharmaceutical companies are creating long-acting injection formulations for a variety of therapeutic areas, such as diabetes, mental health problems, and HIV/AIDS, by utilizing cutting-edge drug delivery technology, such as microspheres, which liposomes, & polymer-based formulations. In addition to the regulated release of these formulations, therapeutic plasma levels are maintained and drug concentration variations are minimized, resulting in more predictable and consistent therapeutic effects. A long-act injectables offer convenience, flexibility, and better control of illness by offering therapy options that are equally beneficial to physicians and patients. Innovation & investment in the IDD sector are being driven by the increasing demand for long-acting injection formulations, which points to a shift in focus toward care that prioritizes patients and customized treatment regimens.

Market Restraining Factors-

High Development and Manufacturing Costs

• The expensive formulations and delivery methods for injectable drugs that come with development and manufacture. To build and improve device efficiency, accessibility, and compatibility with a variety of injectable drugs, as well as to develop novel injectable drug delivery methods like wearable injectors, pen injection devices, and self-injectors, significant spending in study and development and engineering is required. Moreover, complicated formulation creation, testing, and scale-up procedures are required when creating injectable drugs to obtain desirable drug release patterns, stability, & compatibility with delivery systems. Excessive development expenses also apply to manufacturing, where specific tools, setups, and procedures are needed to create injectable medication delivery devices & formulations that meet quality standards and legal criteria. Financial obstacles prevent businesses from entering the injection medication delivery market because of the significant upfront investment and continuing costs related to development and production, especially for small and medium-sized enterprises (SMEs) that have little funding. Cost factors may affect choices made about price, market entry tactics, and product development, which may have an effect on injectable medication delivery solutions' ability to compete and grow.

Report Coverage:

The report will cover the qualitative and quantitative data on the global Injectable Drug Delivery (IDD) Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations:

Injectable Drug Delivery Market Players Analysis:

• Abbott
• D.
• Novartis AG
• Pfizer Inc.
• Baxter
• Gerresheimer AG
• AstraZeneca
• Terumo Medical Corporation
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Schott AG
• Sanofi
• Johnson & Johnson Private Limited
• Mylan N.V.
• West Pharmaceutical Services, Inc.
• SHL Medical AG
• Insulet Corporation
• E3D Elcam Drug Delivery Devices
• Ypsomed AG
• AbbVie Inc.
• Novo Nordisk A/S

Key Industry Developments:

• In January 2022, West was announcing a historic partnership with Corning Incorporated for the distribution of pharmaceutical injectables. As part of the newly formed relationship, Corning's Valor Glass technology will be expanded to enable superior injectable drug packaging and delivery systems for the pharmaceutical industry, with the goal of improving patient safety and facilitating access to life-saving therapies.

Injectable Drug Delivery Market Segmentation Analysis:

By Device Type

• Conventional Injectables
• Pre-filled Syringes
• Auto-Injectors
• Pen-Injectors

By Product

• Freeze-Dried Products
• Injectable Sterile Products

By End-use

• Hospitals
• Homecare Settings
• Clinics
• Others

By Region

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
• LAMEA (Latin America, Middle East, Africa)

The report also helps in understanding Global Injectable Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Injectable Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Injectable Drug Delivery Market make the report investor’s guide.

Global Injectable Drug Delivery Market Segmentation Insights:

The market scope is segmented because of by Device Type, by Product, by End-use.

By Device Type

Based on the Device Type of the market is segmented into Conventional Injectables, Pre-filled Syringes, Auto-Injectors, Pen-Injectors.

Prefilled syringes are expected to lead the market in terms of growth rate throughout the forecast period. Healthcare practitioners are increasingly using pre-filled syringes because they offer a single dose of medication, and patients find them to be non-intrusive and convenient. This is due to both the advancement of medical technology and the rising number of infectious disease cases.

Patients are able to self-administer their drug dosage by using these syringes. Pharmaceutical businesses can also efficiently decrease medication waste and increase the shelf life of their products by manufacturing these syringes. Previously, the most widely used injectable devices were glass syringes; however, these days, disposable plastic syringes are the most widely used. In the therapeutic domain, pre-filled syringes are also frequently utilized in the administration of blood stimulants and vaccines. These syringes also guarantee that patients get the right dosage. Additionally, they work with a variety of auto-injection and safety systems.

By End-use

Based on the End-use of the market is segmented into Hospitals, Homecare Settings, Clinics, Others.

In 2022, the hospitals segment held a substantial market share. Vaccines and other pharmaceuticals are injected into a patient's vein, muscle, skin, or bone by medical experts in hospitals. Generic injectables are commonly utilized in two medical care areas: operating rooms and intensive care units.

Adult patients may receive up to three different classes of injectable medications during a normal general anesthesia for a range of surgical procedures. A range of injectables, including vasopressors and antiarrhythmics, are necessary for clinicians working in these environments to handle any anesthetic or surgical issues. A common injectable medicine delivery method used in hospitals to give dehydrated patients fluid solutions and electrolytes is intravenous injection. It also helps in administering both local and general anesthetic to patients having surgery or other procedures.

Regional Snapshots:

By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North American region dominated the global injectable drug delivery market. The region's healthcare system is well-established, has invested heavily in research and development, and is marked by expensive medical care. In addition, the growing incidence of chronic illnesses like cancer, diabetes, and autoimmune diseases is fueling the region's need for injectable medication delivery methods. Other drivers propelling the market are the aging population and the need for more advanced drug delivery methods with better safety and efficacy characteristics. Additionally, the FDA and other regulatory bodies in the area have stringent guidelines that ensure the efficacy and safety of injectable medications, which is driving demand for improved drug delivery methods.

The Asia-Pacific market is expected to grow at the fastest rate in terms of revenue over the forecast period due to the rising incidence of chronic illness in developing nations like China and India. Additionally, the region's increasing focus on constructing state-of-the-art healthcare infrastructure, expanding access to healthcare, and increasing R&D spending is making injectable drug delivery systems absolutely essential. The need for injectable pharmaceutical delivery techniques in the region is also being driven by a large patient base and an increasing understanding of healthcare.

Injectable Drug Delivery Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report:

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase:

• To gain insightful analyses of the Injectable Drug Delivery market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the Injectable Drug Delivery market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the Injectable Drug Delivery market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Injectable Drug Delivery Market:

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2031
• Representation of Market revenue in USD Million

Injectable Drug Delivery Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: